THE TECFIDERA CHANNEL: Royalty Pharma Acquires Additional Interest in TECFIDERA (Dimethyl fumarate) for $510 Million

Saturday, June 28, 2014

This acquisition follows Royalty Pharma's previous acquisition of an interest in the Fumapharm earn-out payments in May 2012 for $761 million.

Read more here: http://www.sacbee.com/2014/01/06/6049132/royalty-pharma-acquires-additional.html#storylink=cpy